Prime Therapeutics LLC and
Vice Chancellor Paul A. Fioravanti Jr. dismissed the case Tuesday from Delaware’s Chancery Court, a few hours after the two pharmacy giants told the judge Prime was dropping its contract and fiduciary breach claims.
The filing doesn’t expressly state that there’s a settlement, and attorneys for both sides didn’t immediately respond Tuesday to requests for comment or more information.
But ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.